Novo Nordisk stock news
Novo Nordisk reported its 2025 financial results, with net sales of $43.27 billion and an operating profit of $17.88 billion, reflecting over 10% sales growth at constant exchange rates. The company provided a cautious outlook for 2026, forecasting a 5% to 13% decrease in sales and operating profit, excluding a one--time rebate reversal. Additionally, Novo Nordisk proposed a higher dividend and initiated a $2.1 billion share repurchase program.